Sunday, June 06, 2004

From the Kansas City Star:
Are risks worth the rewards?
The safety issue is being swept aside much too expediently when it comes to the push for liberalization of drug reimportation from Canada.

Even though there is growing political support for congressional approval of foreign-source access, safety concerns are being sacrificed to the clamor for cheaper prescription drugs. The Food and Drug Administration has the authority to sanction reimportation but has been reluctant to do so because for safety reasons.

No comments: